Compare American International Group Inc (AIG) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American International Group Inc vs Mesoblast Limited — how do they compare? American International Group Inc trades at $77.45 (market cap $40.42B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: American International Group Inc is far larger — about 18.3× Mesoblast Limited's market cap, and American International Group Inc pays a 2.59% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| AIG | MESO | |
|---|---|---|
Market Cap | $40.42B | $2.21B |
Sector | Financials | Technology |
52-Week High | $86.59 | $20.96 |
52-Week Low | $71.89 | $12.88 |
Enterprise Value | $48.06B | $2.21B |
Dividend Yield | 2.59% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American International Group Inc
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. Its revenue is split roughly evenly between commercial and consumer lines.
Read more on AIG →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
